Covid19Press Release

COVID-19 Pandemic Lockdown And Guidance Note To Companies That Donate Or Market Breastmilk Substitutes (BMS) For Infants

2 Mins read

The National Agency for Food and Drug Administration and Control (NAFDAC), pursuant to provisions of the NAFDAC Act, CAP N1 LFN 2004 and the MARKETING (BREAST-MILK SUBSTITUTES) ACT CAP M.5 LFN 2004 and the BMS regulations, in keeping with the WHO International Code of Marketing of Breastmilk Substitutes (BMS) wishes to provide the following clarifications regarding donations of breastmilk substitutes (BMS) in the context of lockdown and financial barriers occasioned by the national response to the COVID-19 pandemic.

Companies that market foods for infants and young children (breastmilk substitutes) should not provide free products, samples or reduced-price foods for infants (below 6 months old) to families through health workers or health facilities, except as supplies distributed through Government or officially sanctioned health programmes.

TheWHO International Code of Marketing of Breastmilk Substitutes (BMS) requires that products distributed in such programmes should not display company brands. In this specific instance, the unbranded packaging is to focus on the need to support the response to the COVID-19 pandemic, where necessary in terms of infant and young child feeding, rather than use the pandemic as a platform for brand promotion.

Through this medium the Agency wishes to advise all infant food manufacturers/distributors and non-governmental organizations (NGOs) wishing to make foods for infants and young children (BMS) available for distribution, through officially sanctioned health programmes, to adhere to the clarification provided above and approach NAFDAC for the necessary guidance.

The importance of infant and young child feeding (IYCF) and the continued protection, promotion, and support of breastfeeding during the COVID-19 pandemic cannot be over-emphasized. Breastmilk is the best food for the newborn child as it protects them from sicknesses, it also helps to protect infants and young children. Breastfeeding is especially effective against infectious diseases as it boosts the child’s immunity by directly transferring antibodies from the mother to the child.

For specific advice on breastfeeding in the context of the COVID-19 pandemic please visit the following websites:

WHO for the guidance titled ‘Breastfeeding advice during the COVID-19 outbreak available at:

http://www.emro.who.int/nutrition/nutrition-infocus/breastfeeding-advice-during-covid-19-outbreak.html

UNICEF for the guidance titled Breastfeeding during the COVID-19 pandemic’ available at:  https://www.unicef.org/eap/breastfeeding-during-covid-19

NAFDAC wishes to reassure the general public that the Agency will continue to safeguard public health including neonates and older infants, within the purview of her mandate, as the whole world and Nigeria in particular continues to confront the raging COVID-19 pandemic.

NAFDAC………safeguarding the health of the Nation

Related posts
Press Release

West Africa Unite in Abidjan to Fast-Track Lassa Fever Vaccine and Strengthen Epidemic Preparedness

2 Mins read
The 2nd ECOWAS Lassa Fever International Conference (#ELFIC 2025) concluded this Thursday 11 September 2025 in Abidjan, Côte d’Ivoire, after four days…
Press Release

West African Leaders Commit to Advance Lassa Fever Vaccine For the Region

5 Mins read
In an historic moment for regional solidarity and leadership, West African Ministers of Health pledge their joint commitment to advance the development…
Press Release

Global Experts to Convene in Côte d’Ivoire for the 2nd ECOWAS Lassa Fever International Conference

2 Mins read
Leading scientists, researchers, public health advocates, policymakers, and health practitionersfrom across the globe will converge in Abidjan from 8 to 11 September…

Leave a Reply

Your email address will not be published. Required fields are marked *